HDT BIO CORP
Emcure and its subsidiary Gennova settle legal dispute with HDT Bio over mRNA technologyEmcure Pharmaceuticals and its subsidiary Gennova have resolved all legal disputes with US-based HDT Bio Corp. The parties have entered int...
Here’s why developing countries can make COVID-19 mRNA vaccinesDepending on wealthy nations to donate billions of doses is not working, public health experts say. The solution, many now believe, is for ...
- Load More